Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial. - Yoshimoto T; Saito S; Omae K; Tanaka K; Kita T; Kitamura K; Fukuma K; Washida K; Abe S; Ishiyama H; Yamaguchi E; Yamagami H; et al. (EClinicalMedicine, 2024)